The serotonin 5-HT 4 receptor (where 5-HT stands for 5-hydroxytryptamine) is a member of the seven transmembrane-spanning G-protein-coupled family of receptors and mediates many cellular functions both in the central nervous system and at the periphery. In the present study, we isolated and characterized the 5 -flanking region of the h5-HT 4 (human 5-HT 4 ) receptor. We demonstrate the existence of a novel exon that corresponds to the 5 -untranslated region of the h5-HT 4 receptor gene. RNase protection analysis and reverse transcriptase-PCR experiments performed on human atrial RNA demonstrated that the major transcription start site of the h5-HT 4 receptor gene is located at − 3185 bp relative to the first ATG codon. In addition, a 1.2 kb promoter fragment which drives the transcription of the 5-HT 4 receptor was characterized. The promoter region lacks TATA and CAAT canonical motifs in the appropriate location, but contains putative binding sites for several transcription factors. Transient transfection assays revealed that the (− 3299/− 3050) gene fragment possesses the ability to promote the expression of the luciferase reporter gene in human cell lines. In contrast, the promoter was silent in monkey COS-7 cells, indicating the requirement of specific factors to initiate transcription in human cells. In addition to the promoter element, enhancer activity was found in a region (− 220/− 61) located in the long 5 -untranslated region. Mutational analysis, gel shift and transfection assays identified an Nkx2.5 (NK2-transcription-factor-related 5)-like binding site as a regulatory sequence of this enhancer. Our results suggest a complex regulation of the h5-HT 4 receptor gene expression involving distinct promoters and non-coding exons.
INTRODUCTION
Serotonin (5-HT, 5-hydroxytryptamine) is a major neurotransmitter in both the central nervous system and peripheral tissues. Of the 14 mammalian 5-HT receptor subtypes identified so far, all are G-protein-coupled receptors, with the exception of the 5-HT 3 receptor that belongs to the superfamily of ligand-gated ion channels [1] . The 5-HT 4 receptor was first described as a potent 5-HT receptor capable of inducing cAMP production in primary neuronal cultures from mouse colliculi [2] . Subsequent pharmacological studies have demonstrated the existence of 5-HT 4 receptor responses in the heart, adrenal gland, bladder and digestive tract of various species, including human [3, 4] . In mammalian brain, activation of the 5-HT 4 receptor increases memory and learning [5] . Accordingly, the 5-HT 4 receptor stimulates acetylcholine release in rat frontal cortex [6, 7] and regulates the processing of the amyloid precursor protein [8, 9] . In the peripheral tissues, the 5-HT 4 receptor has been shown to regulate gastrointestinal tract motility, intestinal electrolyte secretion and bladder contraction [4] .
In the heart, 5-HT 4 receptors exert strong positive chronotropic, inotropic and lusitropic effects in human and pig atria. However, unlike β-adrenergic receptors, the 5-HT 4 receptor exerts its effects exclusively on the atrial tissue and has no functional effects on ventricles [10, 11] . In addition, the cardiac effects of the 5-HT 4 receptor are restricted to human and pig atria and are absent from a large number of laboratory animals, such as rat, guinea pig, rabbit and frog [12, 13] . Regarding 5-HT 4 receptor-associated cardiac disorders, there are in vivo, in vitro, and clinical evidence that these receptors can trigger atrial arrhythmia [14] . Therefore the regulation of 5-HT 4 receptor expression is of particular importance to understand their involvement in this cardiac disorder.
Several groups have isolated and sequenced C-terminal splice variants of the h5-HT 4 (human 5-HT 4 ) receptor. A total of eight C-terminal isoforms and one internal splice variant have been currently identified and are named as h5-HT 4(a) , h5-HT 4(b) , h5-HT 4(c) , h5-HT 4(d) , h5-HT 4(e) , h5-HT 4(f) , h5-HT 4(g) , h5-HT 4(n) and h5-HT 4(hb) [15] [16] [17] [18] [19] . These receptors are heptahelical transmembrane receptors that are positively coupled with adenylate cyclase. The h5-HT 4 receptor gene is located on chromosome 5, bands 5q31-q33 [20] and contains five exons encoding the common transmembrane domains of the h5-HT 4 receptor as well as eight alternatively spliced cassettes that code for the internal and C-terminal splice variants [17] . The 5 -UTR (5 -untranslated region) of the h5-HT 4 receptor gene has been recently characterized from human placental cDNA. The 5 -UTR is extremely long in this tissue, since it reached more than 5100 bp upstream from the translation start site and consists of 25 exons and a part of exon 26, which includes the first methionine ( Figure 1A ) [21] . Thus according to the present study the entire h5-HT 4 receptor gene spans more than 700 kb and is divided into at least 38 exons.
To date, there is no detailed information on the identification of the cis-acting elements, which may be involved in the regulation of h5-HT 4 receptor expression. Therefore, to understand further the regulation of the h5-HT 4 receptor gene and its potential implication in cardiac disorders, such as atrial arrhythmia, we characterized its 5 -UTR in human atrial RNA. RT (reverse transcriptase)-PCR experiments and RNA protection assay showed a major transcription start site located within intron 25 at − 3185 bp relative to the first ATG codon. In addition to the promoter element, enhancer activity was found within intron 25 but in a region (− 220/− 61) located in the 5 -UTR. Mutational analysis, gel shift and transfection assays identified an Nkx2.5 (NK2-transcription-factor-related 5)-like binding site as a regulatory sequence of this enhancer.
MATERIALS AND METHODS

Surgery
All methods for obtaining human tissue were approved by the Ethics Committee of the Hôpital de Bicêtre and Université de ParisSud. Specimens of right atrial appendages were obtained from patients undergoing heart surgery for coronary artery diseases or valve replacement at the Institut Hospitalier Jacques Cartier (Massy, France).
Cell culture and products
The human neuronal neuroblastoma cell line IMR32, HEK (human embryonic kidney) and human cervix epitheloid carcinoma (HeLa) cells were purchased from A.T.C.C. (Manassas, VA, U.S.A.) and were grown at 37
• C in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % (v/v) foetal calf serum, 1 % non-essential amino acids and antibiotics in humidified 5 % CO 2 . COS-7 cells were cultured as described previously [15] . Primary cultures of neonatal rat ventricular myocytes were prepared from hearts of 2-3-day-old SpragueDawley rat pups. Briefly, hearts were digested with collagenase and pancreatin. Myocytes were then purified over a Percoll gradient and were plated at a density of 1×10 6 cells per 35 mm dish and cultured overnight in DMEM containing 5 % foetal calf serum and 10 % horse serum. All media, media supplements and sera were obtained from Life Technologies. PCRs were performed with High Fidelity Taq DNA polymerase (Roche Diagnostics, Meylan, France).
Oligonucleotides
Numbering is relative to the first ATG codon. Primers used for the different experiments were designed based on the sequences of the 5-HT 4 receptor cDNA (GenBank ® accession no. Y12507) and the BAC clone CTB-160O22 (GenBank ® accession no. AC008627. . The sequences of S124, S125, S137, S138 and β-actin primers have been described previously [15, 21] .
RT-PCR
Total RNA was prepared from human atrial tissues and cell lines using the TRIzol ® RNA purification system (Life Technologies). After purification, RNA was treated with DNase I (Life Technologies) and 5 µg of total RNA was then hybridized with oligo(dT) primer and reverse-transcribed using Superscript RT II (Life Technologies). The resulting single-strand cDNAs were used as templates in two successive PCRs using the different primers indicated in this paper. Both PCRs were performed using the following cycle conditions: denaturation for 1 min at 94
• C, annealing for 30 s at 58
• C, and extension for 1 min 30 s at 72
• C, with a final extension step for 8 min at 72
• C. The PCR products were electrophoresed on 1-2 % agarose gel containing 0.01 % ethidium bromide and photographed under UV irradiation.
RPA (RNase protection assay)
Total RNA from human atrium was analysed by RPA using the RPA III kit (Ambion, Austin, TX, U.S.A.) and an antisense RNA probe directed against the 5 -flanking sequence (− 3362/− 2970). Template DNA required for the synthesis of the RNA probe was obtained by PCR amplification of the BAC clone CTB-160O22 (Research Genetics, Huntsville, AL, U.S.A.; GenBank ® accession no. AC008627.7). The RNA probe was transcribed (Maxiscript T7 kit; Ambion) in the presence of [α-32 P]UTP (800 Ci/mmol; PerkinElmer Life Science Products, Courtaboeuf, France) and purified on a 5 % polyacrylamide gel. The radiolabelled RNA probe was then hybridized with 50 µg of total RNA from human atrium or HEK cells at 42
• C for 18 h. After digestion with RNase A and RNase T1, protected RNA fragments were separated on an 8 M urea/7 % acrylamide gel. The gel was exposed to X-Omat AR film for 3 days (Eastman Kodak) at − 80
• C.
Reporter construct and luciferase assay DNA fragments were constructed by PCR using the BAC clone CTB-160O22 (GenBank ® accession no. AC008627.7) as a template and were cloned into the luciferase reporter vector, pGL3-Basic in either KpnI-BglII or KpnI-XhoI restriction sites (Promega). The authenticity of the nucleotide sequences was confirmed by DNA sequencing. For cell lines, transient transfections were performed in 24-well plates using polyethyleneimine as described previously [22] . Primary culture of rat neonatal cardiomyocytes maintained for 2 days in vitro were transfected with Lipofectamine TM (Life Technologies) according to the manufacturer's instructions. After transfection, myocytes were cultured overnight in DMEM with 5 % horse serum, then in serum-free medium. After 24 h, cells were harvested and assayed for luciferase activity. Luciferase measurements were performed using the Promega luciferase assay system according to the manufacturer's instructions in a Lumat luminometer. Results are expressed relative to the luminescence obtained with the promoterless pGL3-Basic vector. Each transfection experiment was performed in quadruplicate, repeated at least three times and was normalized per mg of cell protein.
Site-directed mutagenesis
Mutations in the Oct-1 (octamer-binding factor-1), MEF-2 (myocyte enhancer factor-2) and Nkx2.5 consensus binding sites within a region (− 220/− 61) were introduced using Quik Change TM sitedirected mutagenesis kit (Stratagene) using the pGL3 (− 220/ − 61) construct as a template. Sequences of the mutated oligonucleotides used were as follows (sense strand): Mut Oct-1, 5 -GGCTGTACCATACGTCAACGCGCCAAAAGCTTTTTG-CTT-3 ; Mut MEF-2, 5 -GTATTGTTTATTCCCTATTTCCACA-AA-3 ; Mut Nkx2.5, 5 -CAAAACAAGTCACGGTAGGAAGC-AATA-3 .
EMSA (electrophoretic mobility-shift assay) and identification of DNA-binding proteins
Nuclear extracts were prepared from IMR32 cell line as described previously [23] . Nkx2.5 protein was prepared by coupled in vitro transcription/translation of a T7-driven Nkx2.5 plasmid in reticulocyte lysate by using a TNT kit (Promega). The Nkx2.5 gel retardation probe was constructed by annealing complementary synthetic oligonucleotides (5 -AAACAAGTCATA-ATAGGAAGCA-3 ). The oligonucleotide probe was end-labelled with [γ -32 P]ATP (3000 Ci/mmol; PerkinElmer Life Science products) and T4 polynucleotide kinase (Promega) and purified on a G-25 column. The following double-stranded oligonucleotides containing the mutated consensus sequences were used for competition assays: Nkx2.5 mut (5 -AAACAAGTCACGGTA-GGAAGCA-3 ). The Ets-1 (E26 transformation-specific-1) probe has already been described in [42] . Nuclear extracts (20 µg) or 3 µl of programmed lysates were incubated with 0.5 ng of [ 32 P] double-stranded probe in 20 µl of 20 mM Hepes (pH 7.9), 100 mM NaCl, 20 mM KCl, 0.2 mM EDTA, 0.2 mM EGTA, 1 mM dithiothreitol, 0.5 mM PMSF, 10 % (v/v) glycerol and 1 µg of poly(dI/dC) (Amersham Biosciences). For competition studies, before the addition of an Nkx2.5 probe, nuclear extracts were preincubated for 10 min at room temperature (20 • C) with a 50-fold excess of unlabelled Nkx2.5 mut and Ets-1 oligonucleotides. Reaction mixtures were incubated for 30 min at room temperature and DNA-protein complexes were resolved on a nondenaturing 6 % polyacrylamide gel at 20 mA for 3 h in 0.5 × TBE (45 mM Tris/borate and 1 mM EDTA). Gels were vacuumdried and were visualized using the Molecular Dynamics Storm PhosphorImager (Amersham Biosciences).
DNA affinity purification of nuclear proteins was performed using 300 µg of nuclear extracts. The 5 -biotinylated oligonucleotides MEF-2-Control (AAGCTCGCTCTAAAAATAACCCTGT-CCCTGGT), Mut-MEF-2-Control (AAGCTCGCTCTAAGGC-TAACCCTGTCCCTGGT) and MEF-2-5-HT 4 -R (TTAGTATT-GTTTATTAAATATTTCCACAAAAC) were first coupled with streptavidin-agarose beads (Sigma) for 1 h at 4
• C. Nuclear extracts were then incubated for 2 h with the precoated beads. Beads were washed three times and boiled in reducing sample buffer to elute the bound proteins. Proteins were separated on a 10 % polyacrylamide gel and electroblotted on to a PVDF membrane from Amersham Biosciences. Proteins were detected using anti-MEF-2 polyclonal antibody (Santa Cruz Biotechnology; H-300, 1:500) and visualized by the chemiluminescence system (Amersham Biosciences).
Statistical analysis
An unpaired Student's t test was used to evaluate differences between means; differences were considered significant when P < 0.05.
RESULTS
Isolation of the 5 -end of the h5-HT 4 receptor cDNA
To identify further the 5 -end of the h5-HT 4 receptor cDNA in human atria, we performed successive RT-PCR experiments on total RNA extracted from human atria using various oligonucleotide primers based on the h5-HT 4 receptor genomic DNA sequence (GenBank ® accession no. AC008627.7). Since h5-HT 4 receptor mRNAs are weakly expressed in their different target tissues, especially in the atrium [15, 24] , we performed nested PCR to amplify the 5 -upstream sequence. To prevent any amplification of genomic DNA, sense and antisense primers were respectively selected on intron 25 and exon 27 ( Figure 1A ). Using the sense/antisense primers (− 2340/+ 131) and (− 2106/+ 40) in consecutive PCRs, a 2 kb DNA fragment was amplified (results not shown). It displayed full homology with the h5-HT 4 receptor genomic DNA sequence (GenBank ® accession no. AC008627.7), indicating that the 5 -UTR of the h5-HT 4 receptor in human atria extended at least upstream of position − 2340 bp from the ATG codon (results not shown). The 5 -UTR was further explored by performing nested PCR on cDNA using sense primers located upstream of position − 2340 (Figure 2A ). Using as templates the products of a first PCR performed with the couple of primers (− 2837/− 2166), a second nested PCR performed with the sense/antisense primers (− 2762/− 2318) led to the amplification of products of expected sizes ( Figure 2B ). Similarly, two PCRs performed consecutively with the couple (− 2762/− 2166) and the couple (− 2711/− 2318) amplified the predicted products ( Figure 2B ). In contrast, no PCR product was synthesized from reverse-transcribed RNA with the couple of primers (− 3299/− 2166) followed by (− 2837/− 2318), although an obvious fragment of the expected size was amplified from genomic DNA ( Figure 2B ). The specificity of the PCR products was confirmed by Southern-blot analysis using the 32 P-5 -endlabelled internal − 2392 primer ( Figure 2B , right panel). Altogether these results indicated that the transcription start site of the h5-HT 4 receptor gene in human atria was located within a region between − 3299 and − 2837 bp from the ATG codon.
Identification of the transcription start site of the h5-HT 4 receptor gene
To delineate the region containing the transcription start site, PCRs were performed using 3 -antisense primers adjacent to primer − 2340 and progressively further 5 -sense primers (Figure 3) . cDNA from human atria and human genomic DNA were compared. The nested PCR products obtained from this analysis are shown in Figure 3(A) . The primer pair (− 3093/− 2392) allowed the amplification of a DNA fragment of 701 bp from the primary PCR product amplified with the primer pair (− 3134/− 2318). In contrast, no PCR product was synthesized from reversetranscribed RNA with the couple of primers (− 3299/− 2318) followed by (− 3192/− 2392). This was not due to inefficient amplification, since these primer pairs generated products of appropriate size using genomic DNA as a template ( Figure 3A, right panel) . Similarly, no PCR product was synthesized from reverse-transcribed RNA with the couple of primers (− 3192/− 2318) followed by (− 3134/− 2392), although an obvious fragment of the expected size was amplified from genomic DNA ( Figure 3A , right panel). Altogether these results indicate that the main transcriptional start site of the h5-HT 4 receptor gene resides between − 3192 and − 3134 bp in human atria.
To map the transcription start site with another approach, we performed RPA analysis with total RNA isolated from human atrial tissues or HEK cells using a 32 P-labelled RNA probe encompassing the sequence − 3362/− 2970 of the h5-HT 4 receptor gene. As shown in Figure 3 (B, lane 1) , the 392 bp probe hybridized with human atrial RNA was partially protected against degradation and gave a 215 bp fragment. The absence of any specific signal in the lane corresponding to the RNA extracted from HEK cells is in accordance with the observation that these cells do not express the h5-HT 4 receptor as assessed by RT-PCR ( Figure 3B ). These results demonstrated the presence of one major start site within the 5-HT 4 left panel, lane 3). Indeed, seven bases of the forward 22-mer primer − 3192 did not anneal to the template and these missing bases strongly reduced the melting-temperature (T m ) value, thus preventing PCR amplification.
Next, to check whether this transcriptional start site was unique to the heart, we performed nested RT-PCR experiments on RNA extracted from human placenta ( Figure 3C ). In this tissue, the major transcriptional start site of the h5-HT 4 receptor has been previously located in exon 1, which is more than 450 kb from the ATG codon [21] . As shown in Figure 3 (C), no PCR product was obtained in human placenta with primers (− 2837/− 2166) followed by (− 2762/− 2318), whereas a fragment of 444 bp was amplified from human atrial cDNA. Similarly, the primer pair (− 3093/− 2392) allowed the amplification of a DNA fragment of 700 bp from the human heart cDNA product amplified with the primer pair (− 3134/− 2318) ( Figure 3A) . No PCR product was observed when the same experiment was performed on cDNA of human placenta (results not shown). We also demonstrated the presence in heart and placenta tissues of cDNA corresponding to the constitutively expressed β-actin gene ( Figure 3C ), as well as the absence of actin PCR product in a control without RT ( Figure 3C ). Therefore signals obtained in our study were not due to any contaminating genomic DNA, since no bands were observed when RNA was directly amplified. Altogether, these results indicate that the long 5 -UTR and the − 3185 bp start site are unique to the heart. With respect to the finding of Hiroi et al. [21] , we named this new long exon, which contains the 5 -UTR located on intron 25 and exon 26, exon 1 bis ( Figure 3D, upper  panel) .
Interestingly, we found that the start site present in human placenta appeared also to be used in human atria, since we were able to detect by PCR a 220 bp product, which corresponds to a DNA fragment lying between exons 1 and 4 ( Figure 3D, lower panel) . This nested PCR was performed using primers (S137/S124) and (S138/S125), which have been previously shown to amplify specifically these exons [21] . These results suggest that the h5-HT 4 receptor gene may use several transcription initiation sites ( Figure 3D, upper panel) .
Transcriptional activity of the h5-HT 4 receptor promoter
The genomic 5 -flanking sequence lying between positions − 4298 and − 3100 did not contain any canonical TATA sequence nor a CAAT box ( Figure 1B) . Nevertheless, to test whether the region located upstream of exon 1 bis behaved as a functional promoter, three 5 -deletion fragments were generated by PCR and subcloned into the promoterless vector pGL3-Basic (Figure 4) . The largest DNA fragment corresponded to sequence − 4298/ − 3050, whereas the others corresponded to shorter proximal sequences extending from − 3639 to − 3050 and − 3299 to − 3050 (Figure 4 ). To date, there is no in vitro cardiac cellular system expressing endogenous 5-HT 4 receptors that could allow such a functional study. Therefore, the promoter activities of the luciferase constructs were evaluated by transient transfection in three human cell lines, namely IMR32, HeLa and HEK cells, as well as in monkey COS-7 cells. Among these cell lines, only human neuroblastoma IMR32 cells express 5-HT 4 receptor mRNA ( [8] and results not shown). After transfection in COS-7 cells, the different reporter constructs did not produce any significant increase in luciferase activity compared with the control pGL3-Basic vector (Figure 4) , although a strong signal was detected on transfection of the cytomegalovirus promoter linked to the luciferase gene (results not shown). In contrast, all three constructs activate luciferase expression to approx. 1.5-7-fold above control value in transiently transfected human HeLa, HEK and IMR32 
Transcriptional activity of exon 1 bis of the h5-HT 4 receptor
The h5-HT 4 receptor comprised more than 3.1 kb in its 5 -UTR located in exon 1 bis. Since transcriptional regulation by exons has been reported for several genes [25, 26] , we examined the promoter activity of the long 5 -UTR of the h5-HT 4 receptor. To this end, we generated by PCR a series of constructs containing serial 3 -deletions of exon 1 bis, which were subcloned into the pGL3-Basic vector ( Figure 5) . The constructs were then transiently transfected into HeLa, HEK, IMR32 and COS-7 cells and assayed for luciferase activity ( Figure 5 ). As observed with previous constructs, no luciferase activity was detected in COS-7 cells with any of these new constructs ( Figure 5) . A modest, not significant, increase in luciferase activity was obtained with the two constructs − 2340/− 61 and − 1200/− 61 when transfected in human cell lines ( Figure 5) . Deletion of the region from − 1200 to − 845 led to a significant enhancement in transcriptional activity in human cell lines when compared with the pGL3-Basic vector ( Figure 5 ). Most importantly, deletion from − 845 to − 220 produced a > 10-fold increase in luciferase activity in IMR32 and HEK cells ( Figure 5) . Again, the highest relative luciferase activity was observed in HeLa cells (more than 40-fold the control value) ( Figure 5 ). 
An Nkx2.5-like element is required for optimal transcriptional activity of the (− 220/− 61) region
The prediction of potential regulatory elements within the (− 220/ − 61) region was determined by using MatInspector [27] and the TFSearch [28] . We found that it contains putative binding sites for the transcription factors Oct-1, MEF-2 and Nkx2.5. Therefore we examined whether mutations in the binding sites of these transcription factors affected the enhancer activity of the (− 220/− 61) region. Mutations of the Oct-1 consensus binding site did not significantly influence the transcriptional activity of the (− 220/− 61) region in IMR32 cells ( Figure 6A ), although these mutations have been previously shown to be effective in the loss of Oct-1 binding [43] . A mutation in the MEF-2 like binding site induced a slight decrease in the transcription activity (30 %) ( Figure 6A ). However, we were not able to show any binding of MEF-2 proteins to this DNA sequence when we performed DNA affinity purification of nuclear proteins extracted from IMR32 cells (results not shown). Mutations in the Nkx2.5-like binding site reduced the enhancer activity of the (− 220/− 61) region by 70 % (Figure 6A ). These results indicate that the Nkx2.5-like consensus sequence plays a major role in the transcriptional activity of the (− 220/− 61) region.
Gel mobility-shift assay was conducted to determine whether the Nkx2.5 consensus sequence was able to bind nuclear proteins. Two major complexes were formed with the radiolabelled Nkx2.5 probe and proteins extracted from IMR32 cells ( Figure 6B, lane 1) . All bound proteins can be displaced by a 50-fold excess of unlabelled Nkx2.5 consensus sequence ( Figure 6B, lane 3) . Competition with a mutant Nkx2.5-binding site failed to abolish completely the complex formation ( Figure 6B, lane 2) , as did an excess of unlabelled consensus Ets-1 oligonucleotide ( Figure 6B , lane 4). To confirm that Nkx2.5 protein binds to the Nkx2.5 consensus sequence located in the (− 220/− 61) region, an EMSA was performed with in vitro translated Nkx2.5 protein and Nkx2.5 WT (wild-type) and mutated (Mut) probes. As shown in Figure 6 (C), the Nkx2.5 protein was bound to the WT 
DISCUSSION
In the present study, we report the functional characterization of the 5 -flanking region of the h5-HT 4 receptor. RT-PCR experiments combined with the sequencing of the 5 -flanking region of the h5-HT 4 receptor showed that the long 5 -UTR (3.1 kb) lies between the transcription initiation site and the first ATG. Such a long 5 -UTR may reduce RNA translation and lead to low levels of expressed transcripts [29] , as is the case for the h5-HT 4 receptor in the heart [24, 30] . Indeed, self-complementary sequences can form stable stem-loop structures that interfere with the assembly of the preinitiation complex. These stem loops can be further stabilized by the interaction with RNA-binding proteins. Furthermore, the presence of ATG codons located upstream of the start site can inhibit translation by causing premature initiation and thereby prevent the ribosome from reaching the ATG start codon [31] .
Sequence analysis of the 5 -untranslated flanking region of the h5-HT 4 receptor gene indicated that the region upstream of the putative transcriptional start site does not contain any of the typical characteristics of promoter regions, such as a TATA box, CAAT box or the GC-rich region. The TATA-less promoter is a characteristic of G-protein-coupled receptors, and the examples include promoters of the 5-HT 2A and 5-HT 2C receptors [32, 45] . Interestingly, the inspection of the sequence around the transcription initiation site revealed a consensus sequence for an initiator element that consists of the sequence TTCACTTT (Figure 1B) [33] . The initiator element is known to be functionally analogous to the TATA box, since it determines the site of transcription and its direction [33] .
In the present study, we found that, in human atrium, the long 5 -UTR of the h5-HT 4 receptor mRNA is located − 3185 bp upstream of the translation initiation site and is encoded by a single exon (exon 1 bis). This start site is unique to the heart and not present in placenta. However, the start site previously described in placenta was also detected in the heart (Figure 3B) , suggesting that the h5-HT 4 receptor gene may use multiple transcription initiation sites. This is in accordance with previous studies showing that 5-HT 1A , 5-HT 2A and 5-HT 2C receptor genes have several transcription start sites [32, 44, 45] . Therefore the 5 -UTR of the h5-HT 4 receptor is a result of the use of the two alternate promoters. It does not change the protein-coding region, but may affect the transcription efficiency as well as the spatial and temporal expression of the h5-HT 4 receptor. The reason for the complex arrangement of numerous start sites spread over an extended domain remains obscure. Perhaps these mRNAs are differentially regulated at the level of translation in different cell types. Alternatively, the transcription initiation sites may be regulated independently, providing a potential mechanism to control transcription of the gene differentially in different cell types and tissue regions, as has been shown for several genes [46] .
Transient transfection assays with a series of h5-HT 4 receptor promoter-luciferase constructs identified an approx. 1.2 kb fragment of 5 -non-transcribed sequence that was active as a promoter in the human cell lines, IMR32, HEK and HeLa, and silent in COS-7 cells. These results suggest that this DNA fragment is necessary to drive cell-specific expression of the 5-HT 4 promoter. Progressive deletion of the h5-HT 4 promoter resulted in an increase in luciferase activity in human cells, but not in monkey COS-7 cells. This indicates that the sequences immediately upstream of the transcription start site probably contain positive elements that are required to enhance transcription in the human cell lines tested. Surprisingly, we found that the DNA region − 845/− 61 of exon 1 bis increased luciferase activity on transfection in human cells. Deletion of the region located between − 845 and − 220 further enhanced luciferase expression, indicating the presence of strong positive elements between positions − 220 and − 61. Analysis of the (− 220, − 61) region by MatInspector and TransFac programs revealed that it contains putative binding sites for several transcription factors such as Oct-1 and Nkx2.5. Mutational analysis of either consensus sequence showed that the Nkx2.5-like binding site strongly regulates transcriptional activity of the (− 220/− 61) region. EMSA demonstrates specific binding of nuclear proteins to a portion of this region containing the Nkx2.5-binding site.
Nkx2.5 (also called Csx) is a member of the NK class of homeodomain proteins required for cardiac commitment, differentiation and morphogenesis [36] . This transcription factor is continually expressed from embryonic stage to adulthood in human heart [37] . Nkx2.5 has been shown to regulate transcription of markers of cardiac hypertrophy, such as the skeletal α-actin [38] and the atrial natriuretic factor [39] . However, Nkx2.5 by itself is a weak transactivator and requires additional interactions with other transcription factors, such as serum response factor or GATA-4 [40, 41] . The potential MEF-2-binding site located in the proximity of the Nkx2.5-binding site would have been a good partner, since MEF-2 response elements have been reported in several cardiac promoters and their mutations have been shown to decrease promoter activity [34, 35] . However, when we performed DNA affinity purification using the MEF-2-like binding site as a probe, we were not able to detect any binding of MEF-2 proteins to this DNA sequence (results not shown). Thus the partners of NKx2.5 have to be defined.
In summary, we have identified a second transcription start site of the h5-HT 4 receptor gene, which is under the control of a promoter region located at more than 3 kb from the first ATG codon. We also provide evidence that the long 5 -UTR isolated in this study is only coded by one exon in human atrium. The (− 220/ − 61) region contains an Nkx2.5-like element, which regulates the transcriptional activity of the h5-HT 4 receptor gene.
